CTIC is a buy
March 29, 2009
Cell Therapeutics, Inc.
CTIC is a buy as of Monday, March 30th, 2009 @ $0.35
I will hold and expect to sell around $0.80 possibly within a few days or by the end of the week. This stock has jumped from avg. volume of 9 million to 85 million. Alot of speculation about it’s new Pixantrone and how it is 81% more effective than the mainstream chemotherapy against the fight on cancer. The drug is now in phase III and is expecting fast track FDA approval into marketing and selling the drug by December. If this holds true, annual sales of one billion dollars by 2014 have been calculated.
Random Posts
Posted in Alternative Energy, World News
content rss
March 30th, 2009 at 12:49 am
I just found this website.Just bookmarked it.Really like the “live Bloomberg TV”
March 30th, 2009 at 1:35 am
Thanks alot Alex
March 30th, 2009 at 12:42 pm
Cell Genesys (CEGE) offers greater near term upside due to new finding of significant survival benefit and erroneous determination of deaths, including meaningful insider buying, strong cash position, and majority ownership of Ceregene who again advanced pivotal triials in gene therapy treatments. Once over .42 the stock could easily go to $1.00 short term. Company has value of at least $1.27 per share.
May 24th, 2009 at 5:50 am
CTIC GO STRONG HOLD LONG!
October 1st, 2009 at 3:14 am
Many people have lost their confidence in investing. However, even in a bad economy, there are good investment opportuntities. I happen to think stock in Mentor Capital (MNTR) is one of them.